The role of CXCL10 as a biomarker for immunological response among patients with leprosy: a systematic literature review

View article
Microbiology

Main article text

 

Introduction

Survey methodology

Study design

Inclusion and exclusion criteria

Study selection

Quality assessment

Risk bias assessment

Data extraction and analysis

Results

Study selection

Quality and risk of bias

Study characteristics

Study results

CXCL10 in leprosy reaction

CXCL10 as diagnostic properties

CXCL10 and neuropathy

CXCL10 and leprosy’s therapy

Discussion

CXCL10 as diagnostic properties

CXCL10 in leprosy reaction

Clinical implication

Limitation of study

Conclusions

Supplemental Information

PRISMA checklist.

DOI: 10.7717/peerj.17170/supp-1

Rationale for conducting the systematic review.

DOI: 10.7717/peerj.17170/supp-2

Additional Information and Declarations

Competing Interests

The authors declare that they have no competing interests.

Author Contributions

Flora Ramona Sigit Prakoeswa conceived and designed the experiments, authored or reviewed drafts of the article, and approved the final draft.

Nabila Haningtyas conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, and approved the final draft.

Listiana Masyita Dewi conceived and designed the experiments, authored or reviewed drafts of the article, and approved the final draft.

Ellen Josephine Handoko performed the experiments, analyzed the data, prepared figures and/or tables, and approved the final draft.

Moch. Tabriz Azenta performed the experiments, authored or reviewed drafts of the article, and approved the final draft.

Muhana Fawwazy Ilyas performed the experiments, analyzed the data, prepared figures and/or tables, and approved the final draft.

Data Availability

The following information was supplied regarding data availability:

This is a systematic review.

Funding

The authors received no funding for this work.

2 Citations 1,094 Views 44 Downloads